The STEP 4Life Trial
Alzheimer Disease, At Risk, Alzheimer Disease, Protection Against, Dementia
About this trial
This is an interventional health services research trial for Alzheimer Disease, At Risk focused on measuring Alzheimers Disease, Gamification, Physical activity, Behavioral Science
Eligibility Criteria
Inclusion Criteria:
- own a smartphone
- be enrolled in GeneMatch
- know their genetic testing results (APOE4)
- able to provide informed consent
Exclusion Criteria:
- Inability to provide informed consent
- does not have daily access to a smartphone compatible with the wearable device and not willing to use a device that we can provide them
- already enrolled in another physical activity study
- unable to ambulate independently
- any other medical conditions that would prohibit participation in physical activity program
Sites / Locations
- Blockley Hall
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control
Gamification
Participants will receive a wearable device (e.g. FitBit) but no other interventions during the intervention or follow-up periods.Participants will also complete milestones within the study, such as the cognition and function assessment during weeks 1- 2, and 15-16. Participants will complete an end-of-study questionnaire on their experience with the wearable device and time in the study.
Intervention participants will receive a wearable device (e.g. FitBit) and will enter a game designed with behavioral economics concepts to address predictable barriers to behavior change during a 12-week intervention period. At the end of the 12 week intervention period, participants will enter a 6 week follow-up period during which interventions will cease but passive data collection of step counts will continue. Participants will also complete milestones within the study, such as the cognition and function assessment during weeks 1- 2, and 15-16. Participants will complete an end-of-study questionnaire on their experience with the wearable device and intervention design.